Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Dec 4, 2022
Date Accepted: Mar 12, 2023

The final, peer-reviewed published version of this preprint can be found here:

Smartphone and Mobile App Use Among Physicians in Clinical Practice: Scoping Review

Lee M, Bin Mahmood ABS, Lee ES, Smith HE, Tudor Car L

Smartphone and Mobile App Use Among Physicians in Clinical Practice: Scoping Review

JMIR Mhealth Uhealth 2023;11:e44765

DOI: 10.2196/44765

PMID: 37000498

PMCID: 10131676

Smartphone and mobile app use among doctors in clinical practice: a scoping review

  • Mauricette Lee; 
  • Abu Bakar Shakran Bin Mahmood; 
  • Eng Sing Lee; 
  • Helen Elizabeth Smith; 
  • Lorainne Tudor Car

ABSTRACT

Background:

Healthcare professionals increasingly use smartphones in clinical care. Smartphone use can affect patient quality of care and clinical outcomes.

Objective:

This scoping review aimed to describe how smartphones and mobile apps were used by doctors within clinical settings.

Methods:

We conducted a scoping review using the Joanna Briggs Institute methodology and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses: Extension for Scoping Reviews guidelines. We used the following databases in our literature search: MEDLINE, Embase, Cochrane Library, Web of Science, Google Scholar, and the grey literature source for studies published from 2010. An additional search was also performed by scanning the reference lists of included studies. A narrative synthesis approach was used.

Results:

A total of 10 studies included in this review were published between 2016 and 2021. Eight studies used surveys, and two studies used surveys with focus group study designs to explore the use, adoption, experience, and views on the use of smartphones among doctors. There were studies with only General Practitioners (GPs) (n=3), studies with only specialists (n=3), and studies with both GPs and specialists (n=4). Doctors use smartphones and mobile apps for communication (n=9), clinical decision-making (n=7), drug compendium (n=7), medical education and training (n=7), maintaining health records (n=4), managing time (n=4), and monitoring patients (n=2) in clinical practice. The Medscape medical app was frequently used for information gathering. WhatsApp, a non-medical app, was commonly used for doctor-patient communication. The commonly reported barriers were lack of regulatory oversight, privacy concerns, and limited Wi-Fi or internet access. The commonly reported facilitator was convenience and having access to evidence-based medicine, clinical decision-making support, and a wide array of apps.

Conclusions:

Smartphones and mobile apps were used for communication, medical education and training, clinical decision-making, and drug compendiums in most studies. Although the benefits of smartphones and mobile apps for doctors at work were promising, there were concerns about patient privacy and confidentiality. Legislation is urgently needed to protect the liability of healthcare professionals using smartphones.


 Citation

Please cite as:

Lee M, Bin Mahmood ABS, Lee ES, Smith HE, Tudor Car L

Smartphone and Mobile App Use Among Physicians in Clinical Practice: Scoping Review

JMIR Mhealth Uhealth 2023;11:e44765

DOI: 10.2196/44765

PMID: 37000498

PMCID: 10131676

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.